These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 12761494)

  • 21. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation.
    Liu H; Perlman H; Pagliari LJ; Pope RM
    J Exp Med; 2001 Jul; 194(2):113-26. PubMed ID: 11457886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
    Müerköster S; Arlt A; Sipos B; Witt M; Grossmann M; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
    Cancer Res; 2005 Feb; 65(4):1316-24. PubMed ID: 15735017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.
    El-Rayes BF; Ali S; Ali IF; Philip PA; Abbruzzese J; Sarkar FH
    Cancer Res; 2006 Nov; 66(21):10553-9. PubMed ID: 17079479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways.
    Grandage VL; Gale RE; Linch DC; Khwaja A
    Leukemia; 2005 Apr; 19(4):586-94. PubMed ID: 15703783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
    Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM
    J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells.
    Wang Y; Kuramitsu Y; Baron B; Kitagawa T; Tokuda K; Akada J; Maehara SI; Maehara Y; Nakamura K
    Int J Oncol; 2017 Feb; 50(2):606-612. PubMed ID: 28000865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the phosphatidylinositol 3'-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines.
    Takeda A; Osaki M; Adachi K; Honjo S; Ito H
    Pancreas; 2004 Apr; 28(3):353-8. PubMed ID: 15084985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1.
    Melisi D; Xia Q; Paradiso G; Ling J; Moccia T; Carbone C; Budillon A; Abbruzzese JL; Chiao PJ
    J Natl Cancer Inst; 2011 Aug; 103(15):1190-204. PubMed ID: 21743023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
    Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
    Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
    Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.
    Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
    Clin Cancer Res; 2005 May; 11(9):3433-8. PubMed ID: 15867245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.
    Krystal GW; Sulanke G; Litz J
    Mol Cancer Ther; 2002 Sep; 1(11):913-22. PubMed ID: 12481412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation.
    Hatano E; Brenner DA
    Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
    Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
    Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes.
    Osawa Y; Banno Y; Nagaki M; Brenner DA; Naiki T; Nozawa Y; Nakashima S; Moriwaki H
    J Immunol; 2001 Jul; 167(1):173-80. PubMed ID: 11418646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
    Rabi T; Huwiler A; Zangemeister-Wittke U
    Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas.
    Semba S; Moriya T; Kimura W; Yamakawa M
    Pancreas; 2003 Apr; 26(3):250-7. PubMed ID: 12657951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.
    Simon PO; McDunn JE; Kashiwagi H; Chang K; Goedegebuure PS; Hotchkiss RS; Hawkins WG
    Int J Cancer; 2009 Aug; 125(4):942-51. PubMed ID: 19405118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LY294002 enhances inhibitory effect of gemcitabine on proliferation of human pancreatic carcinoma PANC-1 cells.
    Ke XY; Wang Y; Xie ZQ; Liu ZQ; Zhang CF; Zhao Q; Yang DL
    J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):57-62. PubMed ID: 23392708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.